311 related articles for article (PubMed ID: 33139318)
21. Pharmacological In Vivo Inhibition of S-Nitrosoglutathione Reductase Attenuates Bleomycin-Induced Inflammation and Fibrosis.
Luzina IG; Lockatell V; Todd NW; Kopach P; Pentikis HS; Atamas SP
J Pharmacol Exp Ther; 2015 Oct; 355(1):13-22. PubMed ID: 26209236
[TBL] [Abstract][Full Text] [Related]
22. Role of Sialidase in Long-Term Potentiation at Mossy Fiber-CA3 Synapses and Hippocampus-Dependent Spatial Memory.
Minami A; Saito M; Mamada S; Ieno D; Hikita T; Takahashi T; Otsubo T; Ikeda K; Suzuki T
PLoS One; 2016; 11(10):e0165257. PubMed ID: 27783694
[TBL] [Abstract][Full Text] [Related]
23. Dependence of pathogen molecule-induced toll-like receptor activation and cell function on Neu1 sialidase.
Amith SR; Jayanth P; Franchuk S; Siddiqui S; Seyrantepe V; Gee K; Basta S; Beyaert R; Pshezhetsky AV; Szewczuk MR
Glycoconj J; 2009 Dec; 26(9):1197-212. PubMed ID: 19430901
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of human neuraminidase 3 (NEU3) by C9-triazole derivatives of 2,3-didehydro-N-acetyl-neuraminic acid.
Zou Y; Albohy A; Sandbhor M; Cairo CW
Bioorg Med Chem Lett; 2010 Dec; 20(24):7529-33. PubMed ID: 21036040
[TBL] [Abstract][Full Text] [Related]
25. NEU1 Sialidase Regulates Membrane-tethered Mucin (MUC1) Ectodomain Adhesiveness for Pseudomonas aeruginosa and Decoy Receptor Release.
Lillehoj EP; Hyun SW; Liu A; Guang W; Verceles AC; Luzina IG; Atamas SP; Kim KC; Goldblum SE
J Biol Chem; 2015 Jul; 290(30):18316-31. PubMed ID: 25963144
[TBL] [Abstract][Full Text] [Related]
26. Homology modeling of human sialidase enzymes NEU1, NEU3 and NEU4 based on the crystal structure of NEU2: hints for the design of selective NEU3 inhibitors.
Magesh S; Suzuki T; Miyagi T; Ishida H; Kiso M
J Mol Graph Model; 2006 Oct; 25(2):196-207. PubMed ID: 16427342
[TBL] [Abstract][Full Text] [Related]
27. Emodin alleviates bleomycin-induced pulmonary fibrosis in rats.
Guan R; Zhao X; Wang X; Song N; Guo Y; Yan X; Jiang L; Cheng W; Shen L
Toxicol Lett; 2016 Nov; 262():161-172. PubMed ID: 27717887
[TBL] [Abstract][Full Text] [Related]
28. Neuraminidase 1 promotes renal fibrosis development in male mice.
Chen QQ; Liu K; Shi N; Ma G; Wang P; Xie HM; Jin SJ; Wei TT; Yu XY; Wang Y; Zhang JY; Li P; Qi LW; Zhang L
Nat Commun; 2023 Mar; 14(1):1713. PubMed ID: 36973294
[TBL] [Abstract][Full Text] [Related]
29. Sialidase expression in activated human T lymphocytes influences production of IFN-gamma.
Nan X; Carubelli I; Stamatos NM
J Leukoc Biol; 2007 Jan; 81(1):284-96. PubMed ID: 17028199
[TBL] [Abstract][Full Text] [Related]
30. Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways.
Dong XW; Jia YL; Ge LT; Jiang B; Jiang JX; Shen J; Jin YC; Guan Y; Sun Y; Xie QM
Toxicology; 2017 Aug; 389():31-41. PubMed ID: 28694203
[TBL] [Abstract][Full Text] [Related]
31. Identification of Selective Nanomolar Inhibitors of the Human Neuraminidase, NEU4.
Albohy A; Zhang Y; Smutova V; Pshezhetsky AV; Cairo CW
ACS Med Chem Lett; 2013 Jun; 4(6):532-7. PubMed ID: 24900705
[TBL] [Abstract][Full Text] [Related]
32. Soluble epoxide hydrolase inhibitor 1-trifluoromethoxyphenyl-3- (1-propionylpiperidin-4-yl) urea attenuates bleomycin-induced pulmonary fibrosis in mice.
Zhou Y; Yang J; Sun GY; Liu T; Duan JX; Zhou HF; Lee KS; Hammock BD; Fang X; Jiang JX; Guan CX
Cell Tissue Res; 2016 Feb; 363(2):399-409. PubMed ID: 26310139
[TBL] [Abstract][Full Text] [Related]
33. Effects of thymosin β4 and its N-terminal fragment Ac-SDKP on TGF-β-treated human lung fibroblasts and in the mouse model of bleomycin-induced lung fibrosis.
Conte E; Iemmolo M; Fruciano M; Fagone E; Gili E; Genovese T; Esposito E; Cuzzocrea S; Vancheri C
Expert Opin Biol Ther; 2015; 15 Suppl 1():S211-21. PubMed ID: 26098610
[TBL] [Abstract][Full Text] [Related]
34. Sialidase inhibitors attenuate pulmonary fibrosis in a mouse model.
Karhadkar TR; Pilling D; Cox N; Gomer RH
Sci Rep; 2017 Nov; 7(1):15069. PubMed ID: 29118338
[TBL] [Abstract][Full Text] [Related]
35. Mitogen-activated Protein Kinase-activated Protein Kinase 2 Inhibition Attenuates Fibroblast Invasion and Severe Lung Fibrosis.
Liang J; Liu N; Liu X; Mena JM; Xie T; Geng Y; Huan C; Zhang Y; Taghavifar F; Huang G; Kurkciyan A; Barron V; Jiang D; Noble PW
Am J Respir Cell Mol Biol; 2019 Jan; 60(1):41-48. PubMed ID: 30130411
[TBL] [Abstract][Full Text] [Related]
36. Gefitinib attenuates murine pulmonary fibrosis induced by bleomycin.
Wang P; Tian Q; Liang ZX; Yang Z; Xu SF; Sun JP; Chen LA
Chin Med J (Engl); 2010 Aug; 123(16):2259-64. PubMed ID: 20819676
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic administration of inhaled INS1009, a treprostinil prodrug formulation, inhibits bleomycin-induced pulmonary fibrosis in rats.
Corboz MR; Zhang J; LaSala D; DiPetrillo K; Li Z; Malinin V; Brower J; Kuehl PJ; Barrett TE; Perkins WR; Chapman RW
Pulm Pharmacol Ther; 2018 Apr; 49():95-103. PubMed ID: 29408757
[TBL] [Abstract][Full Text] [Related]
38. Long-term treatment with fasudil improves bleomycin-induced pulmonary fibrosis and pulmonary hypertension via inhibition of Smad2/3 phosphorylation.
Bei Y; Hua-Huy T; Duong-Quy S; Nguyen VH; Chen W; Nicco C; Batteux F; Dinh-Xuan AT
Pulm Pharmacol Ther; 2013 Dec; 26(6):635-43. PubMed ID: 23928001
[TBL] [Abstract][Full Text] [Related]
39. Megakaryoblastic leukemia-1 is required for the development of bleomycin-induced pulmonary fibrosis.
Bernau K; Ngam C; Torr EE; Acton B; Kach J; Dulin NO; Sandbo N
Respir Res; 2015 Mar; 16(1):45. PubMed ID: 25885656
[TBL] [Abstract][Full Text] [Related]
40. Heterodimerization of the sialidase NEU1 with the chaperone protective protein/cathepsin A prevents its premature oligomerization.
Bonten EJ; Campos Y; Zaitsev V; Nourse A; Waddell B; Lewis W; Taylor G; d'Azzo A
J Biol Chem; 2009 Oct; 284(41):28430-28441. PubMed ID: 19666471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
